ADCT Earnings

Quarterly EPS
$-0.38
Q2 2024
$-0.42
Q3 2024
$-0.29
Q4 2024
$-0.36
Q1 2025
$-0.50
Q2 2025
$-0.30
Q3 2025
$-0.04
Q4 2025
$-0.21
Q1 2026
Latest Revenue20.9M
Latest Net Income-32968000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.2120.9M-32968000-9.5%+41.7%
Q4 2025-$0.0423.1M-6409000+36.4%+86.2%
Q3 2025-$0.3016.4M-40966000-11.0%+28.6%
Q2 2025-$0.5018.8M-56646000+8.2%-31.6%
Q1 2025-$0.3623.0M-38602000+27.6%+35.7%
Q4 2024-$0.2916.9M-30727000+0.7%+71.8%
Q3 2024-$0.4218.5M-43969000+27.4%+26.3%
Q2 2024-$0.3817.4M-36544000-9.7%+36.7%
Q1 2024-$0.5618.1M-46606000
Q4 2023-$1.0316.8M-85031000
Q3 2023-$0.5714.5M-46726000
Q2 2023-$0.6019.3M-48922000
ADC Therapeutics SA (ADCT) — Earnings